Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01
Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872-880.
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-972.
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-5812.
High dose rate intracavitary brachytherapy for carcinoma of the cervix: The madison system: II. Procedural and physical considerations
Thomadsen BR, Shahabi S, Stitt JA, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys 1992; 24: 349-357.
High dose rate intracavitary brachytherapy for carcinoma of the cervix: The madison system: I. Clinical and radiobiological considerations
Stitt JA, Fowler JF, Thomadsen BR, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992; 24: 335-348.
International Commission on Radiation Units and Measurements ICRU Report No. 38. Bethesda, MD: International Commission on Radiation Units and Measurements
International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Report No. 38. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985.
National Cancer Institute US Department of Health and Human Services, National Cancer Institute
National Cancer Institute. Common terminology criteria for adverse events (CTCAE). US Department of Health and Human Services, National Cancer Institute; 2010.
Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix
Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 2006; 16: 288-293.
Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: Analysis of risk factors
Oh D, Huh SJ, Nam H, et al. Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors. Int J Radiat Oncol Biol Phys 2008; 70: 1183-1188.
Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix
Eifel PJ, Levenback C, Wharton JT, et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995; 32: 1289-1300.
Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer
Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 2002; 20: 3651-3657.